Holly Fernandez Lynch JD, MBE
Assistant Professor of Medical Ethics and Health Policy at the Hospital of the University of Pennsylvania
Assistant Faculty Director , Online Education Initiatives, Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania
Affiliated Faculty, Center for Technology, Innovation, and Competition, Penn Carey Law School
Antiracism, Diversity, Equity, & Inclusion (ADEI) Vice Chair, Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine
Department: Medical Ethics and Health Policy
Contact information
Blockley Hall, Room 1426
423 Guardian Drive
Philadelphia, PA 19104
423 Guardian Drive
Philadelphia, PA 19104
Office: 215-746-7327
Links
A resource for locating diverse, underrepresented bioethics scholars
Public website for the Advancing Effective Research Ethics Oversight (AEREO) Consortium
A resource for locating diverse, underrepresented bioethics scholars
Public website for the Advancing Effective Research Ethics Oversight (AEREO) Consortium
Education:
BA (Health and Societies)
University of Pennsylvania College of Arts and Sciences, 2003.
MBE (Bioethics)
University of Pennsylvania School of Medicine, 2006.
JD (Law)
University of Pennsylvania Law School, 2006.
Permanent linkBA (Health and Societies)
University of Pennsylvania College of Arts and Sciences, 2003.
MBE (Bioethics)
University of Pennsylvania School of Medicine, 2006.
JD (Law)
University of Pennsylvania Law School, 2006.
Selected Publications
Anderson EE, Johnson A, Lynch HF: Inclusive, Engaged, and Accountable Institutional Review Boards. Accountability in Research Page: 1-9, Jun 2023.Ramachandran R, Lynch HF: Should FDA Grant Accelerated Approval to Duchenne Muscular Dystrophy Gene Therapy? MedPage Today May 2023 Notes: https://www.medpagetoday.com/opinion/second-opinions/104574.
Joffe S, Conti RM, Contreras JL, Largent EA, Lynch HF, Mitchell D, Sachs RE, Whelan AM, McCoy MS: Access to Affordable Medicines: Obligations of Universities and Academic Medical Centers. Gene Therapy In press 2023.
Anderson EE, Hurley EA, Serpico K, Johnson A, Rowe J, Singleton M, Bierer BE, Cholka B, Chaudhari S, Lynch HF: Engaging Key Stakeholders to Overcome Barriers to Studying the Quality of Research Ethics Oversight. Research Ethics 19(1): 62-77, 2023.
Lynch HF, Sachs RE, Lee S, Herder M, Ross J, Ramachandran R: Extending the US Food and Drug Administration’s Postmarket Authorities. JAMA Health Forum 4(6): e231313, 2023.
McGuire AL, Lynch HF, Grossman L, Cohen IG: Pressing Regulatory Challenges for Psychedelic Medicines. Science 380(6643): 347-350, 2023.
Rahimzadeh V, Caulfield T, Fogarty J, Auñón-Chancellor S, Borry P, Candia J, Cohen IG, Covington M, Lynch HF, Greely HT, Hanlon M, Hatt J, Low L, Menikoff J, Meslin EM, Platts S, Ravitsky V, Ruttley T, Seidler RD, Sugarman J, Urquieta E, Williams MA, Wolpe PR, Donoviel D, McGuire AL: Ethically Cleared to Launch? Human Research in Commercial Space Flight. Science 381(6665): 1408-1411, 2023.
Lynch HF, Largent EA: Considering Tomorrow’s Patients in Today’s Drug Approvals. BMJ 381: e075000, 2023.
Lynch HF, Hurley E, Taylor HA: Viewpoint: Responding to the Call to Meaningfully Assess IRB Effectiveness (peer reviewed). JAMA 330(3): 221-222, 2023.
Lynch HF: Devil in the Details: Physician Duties and Expanded Access. Journal of Law, Medicine, and Ethics 51(1): 181-184, 2023.